NOVARTIS PHARMACEUTICALS CORPORATION
Patent Owner
Stats
- 79 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 21, 2017 most recent publication
Details
- 79 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,215 Total Citation Count
- Jun 24, 1981 Earliest Filing
- 64 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0324,821 COMPOUNDS CONTAINING S-N-VALERYL-N--VALINE AND (2R,4S)-5-BIPHENYL-4-YL-4-(3-CARBOXY-PROPIONYLAMINO)-2-METHYL-PENTANOIC ACID ETHYL ESTER MOIETIES AND CATIONSJun 21, 16Nov 10, 16[A61K, C07D, C07C]
2010/0267,786 DUAL ACTING PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NE UTRAL ENDOPEPTIDASE (EP) INHIBITORNov 04, 08Oct 21, 10[A61K, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9598712 Chemical process for preparing spiroindolones and intermediates thereofMar 22, 13Mar 21, 17[C12P, C07D, C12N]
9187405 S1P receptor modulators for treating relasping-remitting multiple sclerosisApr 21, 14Nov 17, 15[A61K, C07C]
8877938 Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNov 08, 06Nov 04, 14[A61K, C07D, C07C]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0005,324 Famciclovir for the Treatment of Recurrent Herpes Labialis Using a One-Day TreatmentAbandonedApr 14, 14Jan 01, 15[A61K]
2014/0113,919 COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASMAbandonedJun 13, 12Apr 24, 14[A61K]
8435563 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the sameWithdrawnJan 03, 12May 07, 13[A61K, A61P]
8106081 Combination of organic compounds useful for treating diabetesExpiredFeb 15, 10Jan 31, 12[A61K]
7943647 Process for the preparation of tetrazole derivatives from organo aluminium azidesExpiredJul 15, 04May 17, 11[A61K]
2011/0092,458 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral DiseasesAbandonedDec 22, 10Apr 21, 11[A61K, A61P]
2011/0028,526 VALSARTAN SOLID ORAL DOSAGE FORMS AND METHODS OF MAKING SUCH FORMULATIONSAbandonedFeb 27, 09Feb 03, 11[A61K, A61P]
2010/0323,952 Nucleoside Analogs in Combination Therapy of Herpes Simplex InfectionsAbandonedAug 30, 10Dec 23, 10[A61K]
2010/0303,906 SOLID DOSAGE FORMS OF VALSARTAN AND AMLODIPINE AND METHOD OF MAKING SAMEAbandonedAug 09, 10Dec 02, 10[A61K, B05D, A61P]
2010/0233,253 EXTENDED RELEASE GASTRO-RETENTIVE ORAL DRUG DELIVERY SYSTEM FOR VALSARTANAbandonedAug 29, 07Sep 16, 10[A61K, A61P]
2010/0152,458 COUPLING REACTIONS USEFUL IN THE PREPARATION OF (1H-TETRAZOL-5-YL) BIPHENYL DERIVATIVESAbandonedMar 02, 10Jun 17, 10[C07D]
7728024 Metal salts of 2′-(1H-Tetrazol-5yl)-1.1′-biphenyl-4-carboxaldehydeExpiredJul 10, 06Jun 01, 10[A61K, C07D]
7700784 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivativesExpiredFeb 01, 05Apr 20, 10[C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
